Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia | Critical Care | Full Text
Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia | NEJM
Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis - ScienceDirect
JCM | Free Full-Text | Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory Mycobacterium avium Complex Pulmonary Disease
A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram‐Negative Ventilator‐Associated Pneumonia: IASIS Trial | Semantic Scholar
Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease | Antimicrobial Agents and Chemotherapy
Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports
PDF) Inhaled amikacin versus placebo to prevent ventilator-associated pneumonia: the AMIKINHAL double-blind multicentre randomised controlled trial protocol
Frontiers | Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia – topic of research paper in Medical engineering. Download scholarly article PDF and read for
Dosing | ARIKAYCE® (amikacin liposome inhalation suspension)
Antibiotics | Free Full-Text | How to Use Nebulized Antibiotics in Severe Respiratory Infections
Diagram of the nebulization setup | Download Scientific Diagram
Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports
Antibiotics | Free Full-Text | Pharmacokinetic Characteristics of Nebulized Colistimethate Sodium Using Two Different Types of Nebulizers in Critically Ill Patients with Ventilator-Associated Respiratory Infections
Full article: The role of amikacin in the treatment of nontuberculous mycobacterial disease
Delivery Efficacy of a Vibrating Mesh Nebulizer and a Jet Nebulizer under Different Configurations | Journal of Aerosol Medicine and Pulmonary Drug Delivery
Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia | NEJM
A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP) | Ain-Shams Journal of Anesthesiology | Full Text
PDF) Pharmacokinetics of High Dose Nebulized Amikacin in Mechanically Ventilated Healthy Subjects.
Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia | NEJM
Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine
Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia | Critical Care | Full Text
Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease | Antimicrobial Agents and Chemotherapy
